Fimasartan reduces clinic and home pulse pressure in elderly hypertensive patients: A K-MetS study.

ABSTRACT:

Background

Angiotensin II receptor blockers (ARBs) are recommended for treating patients with hypertension. However, comparative safety and efficacy of ARB use in elderly patients have not been well established. This study was designed to determine the efficacy of fimasartan, an ARB, in hypertensive elderly patients by measuring clinic and home blood pressures (BPs) and evaluating safety compared to nonelderly patients.

Method

In the K-MetS study, a nationwide prospective observational study of hypertensive patients on fimasartan, elderly patients (60 years and older) who were treated for 1 year with fimasartan were recruited. BP was evaluated in clinic and at home.

Results

Of the 6 399 enrolled patients, 2 363 were elderly (46.9% males, mean age 67.3 ± 5.7 years). Fi

SUBMITTER: Cho EJ 

PROVIDER: S-EPMC6456168 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature